MARKSANS.NS Overview

Company Profile

Related stocks

RUBICON.NS • India

RUBICON RESEARCH LIMITED

1,548.5 INR

2.65B USD

PFIZER.NS • India

PFIZER LTD

3,808.2 INR

1.8B USD 1Y -27.7%

4536.T • Japan

SANTEN PHARMACEUTICAL CO

1,684 JPY

3.42B USD 1Y +7.8%

SANOFICONR.NS • India

SANOFI CONS HEALTHC IND L

3,581.7 INR

853.55M USD 1Y -24.8%

300357.SZ • China

WOLWO PHARMA

19.99 CNY

1.57B USD 1Y -30.7%

002019.SZ • China

YIFAN PHARM

9.66 CNY

1.76B USD 1Y -30.7%

SANOFI.BO • India

SANOFI INDIA LTD

2,945.55 INR

700.95M USD 1Y -37%

300181.SZ • China

ZUO LI YAO YE

13.25 CNY

1.39B USD 1Y -25.8%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile

4 Metrics

Country

India

Region

Asia-Pacific

Sector

Healthcare

Industry

Drug Manufacturers - General

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High

5Y Volatility

45.0% p.a.

Max Drawdown (5Y)

-55.6%

Sharpe Ratio (5Y)

0.71

Beta Factor

1.15

Size Class

Mega Cap

Notes & Warnings

Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).

Exemplary balance sheet strength: Very solid ratio of equity to debt.

🔴 Low analyst coverage – higher uncertainty in growth estimates & projections

Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (45.0% p.a.).

Historical Stress Test: Maximum peak-to-trough drawdown of -81.5% in the extended horizon.